Literature DB >> 19955258

Emergence of resistance to third-generation cephalosporin in Shigella--a case report.

Jharna Mandal1, Nivedita Mondal, S Mahadevan, Subhash Chandra Parija.   

Abstract

The emergence of ciprofloxacin resistance in Shigella has shifted the attention to cephalosporins. The first occurrence of third generation cephalosporin-resistant Shigella flexneri was from France. This article reports the first case of cephalosporin-resistant S. flexneri from India. A 12-month-old child was admitted for a 20-day episode of loose stools, non-fetid, with mucus and blood. The stool sample showed the presence of blood and mucus and S. flexneri which was resistant to Ampicillin, Nalidixic acid, Ciprofloxacin, Furoxone, Ceftriaxone and sensitive only to Cefoperazone and sulbactam combination. The child was promptly admitted and treated with a combination of Cefoperazone and sulbactam. The use of this combination was met with success in the present case, and may be considered as a temporary answer to the emerging cephalosporin-resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955258     DOI: 10.1093/tropej/fmp118

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  7 in total

Review 1.  Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas.

Authors:  Margaret Kosek; Pablo Peñataro Yori; Maribel Paredes Olortegui
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

2.  Emergence of ceftriaxone resistant Shigella.

Authors:  Neeraj Goel; Chand Wattal; Dinesh Kaul; V K Khanna
Journal:  Indian J Pediatr       Date:  2011-12-29       Impact factor: 1.967

3.  In Vitro Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin.

Authors:  George P Allen; Kayla A Harris
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

4.  The Recent Trends of Shigellosis: A JIPMER Perspective.

Authors:  Jharna Mandal; Ganesh V; Jennifer Emelda; Mahadevan S; Subhash Chandra Parija
Journal:  J Clin Diagn Res       Date:  2012-11

5.  Clinical and microbiological profiles of shigellosis in children.

Authors:  A V Sangeetha; Subhash Chandra Parija; Iharna Mandal; Sriram Krishnamurthy
Journal:  J Health Popul Nutr       Date:  2014-12       Impact factor: 2.000

6.  Characterization of extended-spectrum beta-lactamase-producing clinical isolates of Shigella flexneri.

Authors:  Jharna Mandal; V Sangeetha; Ankita Das; Subhash Chandra Parija
Journal:  J Health Popul Nutr       Date:  2013-09       Impact factor: 2.000

7.  Shigella Bacteremia in an Immunocompetent Patient.

Authors:  Hayden E Rotramel; Harris S Zamir
Journal:  Cureus       Date:  2021-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.